Related Experiment Videos

Erectile dysfunction and cardiovascular disease

Shane T Russell1, Bijoy K Khandheria, Ajay Nehra

  • 1Department of Urology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.

Mayo Clinic Proceedings
|June 9, 2004
PubMed

Insights

Erectile dysfunction (ED) and cardiovascular disease (CVD) are linked. This review explores their relationship, prevalence, and management strategies for affected patients.

Area of Science:

  • Cardiology
  • Urology
  • Sexual Medicine

Background:

  • Cardiovascular disease (CVD) and erectile dysfunction (ED) are interrelated conditions affecting millions globally.
  • ED prevalence is significant, impacting 10-20 million men in the US and over 100 million worldwide.
  • Millions of myocardial infarction survivors and individuals with existing CVD necessitate understanding sexual function in this population.

Purpose of the Study:

  • To investigate the intricate relationship between ED and the presence of cardiovascular disease.
  • To review the prevalence and pathophysiological links between ED and CVD.
  • To discuss sexual activity risks and management strategies for ED in CVD patients.

Main Methods:

  • Literature review of studies examining ED and cardiovascular disease.
  • Analysis of epidemiological data on ED and CVD prevalence.
  • Synthesis of pathophysiological mechanisms connecting ED and CVD.

Main Results:

  • ED is a strong predictor of underlying cardiovascular disease.
  • Shared risk factors and pathophysiological pathways link ED and CVD.
  • Sexual activity generally poses low risk for stable CVD patients, with specific considerations.

Conclusions:

  • ED serves as an early indicator for cardiovascular disease, highlighting the need for integrated screening.
  • Management of ED in CVD patients requires a comprehensive approach addressing both conditions.
  • Further research is needed to optimize prevention and treatment strategies for comorbid ED and CVD.

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...